ENLIVEX LIMITED (ENLV)

Track ENLV Stock with real-time price updates, overview, analysis, insider insights, and Smart Score ratings. Get Enlivex Therapeutics Ltd news, earnings, and stock analysis — all in one place at TipRanks.

Following the last earnings report on Mar 25, 2026, ENLV's stock price moved — from — to —.

Profit was driven by appreciation in treasury and derivative assets, which reached $2.31B. Shareholders' equity hit $1.93B; webcast starts 9 a.m. ET.

Enlivex Therapeutics (NASDAQ:ENLV - Get Free Report) released its quarterly earnings data on Wednesday. The company reported $12.85 earnings per share for the quarter, beating analysts' consensus estimates of ($0.03) by $12.88.

Enlivex Therapeutics (NASDAQ:ENLV) executives used the company’s fourth-quarter and full-year 2025 earnings call to outline what they described as a “dual-engine” strategy that combines clinical-stage drug development with a digital-asset treasury focused on decentralized prediction markets.